| Serial Number | 85860216 |
| Word Mark | RESANZ |
| Filing Date | Tuesday, February 26, 2013 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 10, 2016 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 9, 2013 |
| Goods and Services | (Based on Intent to Use) Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; (Based on 44(e)) Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 4, 2013 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Basel CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Basel CH |
| Event Date | Event Description |
| Tuesday, October 11, 2016 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, October 10, 2016 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, March 9, 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 8, 2016 | EXTENSION 5 GRANTED |
| Tuesday, March 1, 2016 | EXTENSION 5 FILED |
| Tuesday, March 1, 2016 | TEAS EXTENSION RECEIVED |
| Saturday, September 5, 2015 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 4, 2015 | EXTENSION 4 GRANTED |
| Monday, August 31, 2015 | EXTENSION 4 FILED |
| Monday, August 31, 2015 | TEAS EXTENSION RECEIVED |
| Friday, March 6, 2015 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 5, 2015 | EXTENSION 3 GRANTED |
| Friday, February 27, 2015 | EXTENSION 3 FILED |
| Friday, February 27, 2015 | TEAS EXTENSION RECEIVED |
| Tuesday, September 16, 2014 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 15, 2014 | EXTENSION 2 GRANTED |
| Monday, September 1, 2014 | EXTENSION 2 FILED |
| Monday, September 15, 2014 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, September 1, 2014 | TEAS EXTENSION RECEIVED |
| Tuesday, March 4, 2014 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 28, 2014 | EXTENSION 1 GRANTED |
| Friday, February 28, 2014 | EXTENSION 1 FILED |
| Friday, February 28, 2014 | TEAS EXTENSION RECEIVED |
| Tuesday, September 3, 2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 9, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 9, 2013 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 19, 2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 4, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 3, 2013 | ASSIGNED TO EXAMINER |
| Monday, March 4, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, March 1, 2013 | NEW APPLICATION ENTERED IN TRAM |